VANI — Vivani Medical Cashflow Statement
0.000.00%
- $69.27m
- $39.62m
Annual cashflow statement for Vivani Medical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -33.6 | -14.9 | -8.92 | -13.9 | -25.7 |
Depreciation | |||||
Non-Cash Items | 5.53 | 1.64 | 0.084 | -5.62 | 2.89 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.037 | -3.74 | -0.421 | 0.338 | -1.29 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -27.6 | -16.8 | -9.19 | -18.8 | -23.7 |
Capital Expenditures | -0.493 | -0.33 | -0.014 | -0.338 | -0.887 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | 0.398 | 0 | — | — |
Sale of Fixed Assets | |||||
Cash from Investing Activities | -0.493 | 0.068 | -0.014 | -0.338 | -0.887 |
Financing Cash Flow Items | — | — | 0.002 | 8 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 35 | 8.6 | 75.6 | 63.4 | 0.133 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 6.86 | -8.15 | 66.4 | 44.3 | -24.4 |